References
- Morales A, Heaton J P, Carson C C, III. Andropause: A misnomer for a true clinical entity. J Urol 2000; 163: 705–712
- Myon E, Martin N, Taieb C, Heinemann L A. Experiences with the French Aging Males' Symptoms (AMS) scale. Aging Male 2005; 8: 184–189
- Heinemann L A, Saad F, Zimmermann T, Novak A, Myon E, Badia X, Potthoff P, T'Sjoen G, Pollanen P, Goncharow N P, Kim S, Giroudet C. The Aging Males' Symptoms (AMS) scale: Update and compilation of international versions. Health Qual Life Outcomes 2003; 1: 15
- Crook D. Androgens and the risk of cardiovascular disease. Aging Male 2000; 3: 190–195
- Aging Male Italian Epidemiological Study Group. The Aging Males' Symptoms in the Italian population: Results from a cross sectional study using the AMS scale. Archivio Italiano di Urologia e Andrologia 2006; 78: 87–91
- Aging Male Italian Epidemiological Study Group. Frequenza dei sintomi della sindrome da aging male nella popolazione generale italiana sopra i 55 anni e loro relazione con la qualità della vita ed i fattori di rischio cardiovascolare: I risultati dello studio AMIES. Giornale Italiano di Medicina Sociale e Riproduttiva 2007; 14: 63
- Heinemann K, Zimmermann T, Vermeulen A, Thiel C, Hummel A. A new Aging Males' Symptoms rating scale. Aging Male 1999; 2: 105–114
- Heinemann L A, Saad F, Heinemann K, Thai D M. Can results of the Aging Males' Symptoms (AMS) scale predict those of screening scales for androgen deficiency?. Aging Male 2004; 7: 211–218
- Daig I, Heinemann L A, Kim S, Leungwattanakij S, Badia X, Myon E, Moore C, Saad F, Potthoff P, Thai D M. The Aging Males' Symptoms (AMS) scale: Review of its methodological characteristics. Health Qual Life Outcomes 2003; 1: 77
- Heinemann K, Saad F, Thiele K, Wood-Dauphinee S. The Aging Males' Symptoms rating scale: Cultural and linguistic validation into English. Aging Male 2001; 4: 14–22
- Sacco M, Corica F, Paolisso G, Maugeri D, Maggio M, Valenti F, Strollo F. Validazione culturale e linguistica di un questionario per definire il deficit androgenico nell'invecchiamento maschile. G Gerontol 2004; 52: 74–80
- Gandek B, Ware J E, Aaronson N K, Apolone G, Bjorner J B, Brazier J E, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: Results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 1171–1178
- Kodraliu G, Mosconi P, Groth N, Carmosino G, Perilli A, Gianicolo E A, Rossi C, Apolone G. Subjective health status assessment: Evaluation of the Italian version of the SF-12 Health Survey. Results from the MiOS Project. J Epidemiol Biostat 2001; 6: 305–316
- Baker R, Nelder J. The GLIM system. Release. Numerical Algorithms Group, Oxford 1978
- Lunenfeld B. Testosterone deficiency and the metabolic syndrome. Aging Male 2007; 10: 53–56
- Svartberg J, Jorde R. Endogenous testosterone levels and smoking in men. The fifth Tromso study. Int J Androl 2007; 30: 137–143
- Walter M, Gerhard U, Gerlach M, Weijers H G, Boening J, Wiesbeck G A. Controlled study on the combined effect of alcohol-dependent men. Alcohol Alcohol 2007; 42: 19–23